{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:44:52Z","timestamp":1791423892758,"version":"4.3.3"},"reference-count":82,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.bbalip.2006.06.008","type":"journal-article","created":{"date-parts":[[2006,7,9]],"date-time":"2006-07-09T11:06:52Z","timestamp":1152443212000},"page":"1301-1308","source":"Crossref","is-referenced-by-count":52,"title":["Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis"],"prefix":"10.1016","volume":"1761","author":[{"given":"Birgitta","family":"Rosengren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Cathrine","family":"J\u00f6nsson-Rylander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Peilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Camejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hurt-Camejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2006.06.008_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00107-5","article-title":"Association of apoB lipoproteins with arterial proteoglycans: pathological significance and molecular basis","volume":"139","author":"Camejo","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2741\/1248","article-title":"Lipoprotein\u2013matrix interactions in macrovascular disease in diabetes","volume":"9","author":"Tannock","year":"2004","journal-title":"Front Biosci."},{"key":"10.1016\/j.bbalip.2006.06.008_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.ATV.5.6.644","article-title":"Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta","volume":"5","author":"Guyton","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0021-9150(94)05405-8","article-title":"Intimal thickenings of human aorta contain modified reassembled lipoproteins","volume":"112","author":"Tirziu","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.ATV.19.4.847","article-title":"Ultrastructure of early lipid accumulation in apoE-deficient mice","volume":"19","author":"Tamminen","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib6","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI119813","article-title":"Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions","volume":"100","author":"Napoli","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2006.06.008_bib7","first-page":"389","article-title":"Properties of lipoprotein complexes isolated by affinity chromatography from human aorta","volume":"44","author":"Camejo","year":"1985","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.ATV.8.6.768","article-title":"Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits","volume":"8","author":"Daugherty","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/hh1601.095598","article-title":"Phospholipase A2 in vascular disease","volume":"89","author":"Hurt-Camejo","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.mol.0000169355.20395.55","article-title":"Secretory phospholipase A2 enzymes in atherogenesis","volume":"16","author":"Webb","year":"2005","journal-title":"Curr. Opin. Lipid."},{"key":"10.1016\/j.bbalip.2006.06.008_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.ATV.21.6.1053","article-title":"Lipolysis of LDL by human secretory phospholipase A2 induces particle fusion and enhances the retention of LDL to human aortic proteoglycans","volume":"21","author":"Hakala","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib13","doi-asserted-by":"crossref","first-page":"26307","DOI":"10.1074\/jbc.271.42.26307","article-title":"Binding of human phospholipase A2 type II to proteoglycans: differential effect of glycosaminoglycans on enzyme activity","volume":"271","author":"Sartipy","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-2275(20)38493-5","article-title":"Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification","volume":"29","author":"Sparrow","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib15","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","article-title":"Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH","volume":"273","author":"Schissel","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib16","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1021\/bi9730745","article-title":"Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid paroxidation in low density lipoproteins","volume":"37","author":"Neuzil","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2006.06.008_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/01.ATV.0000069208.20268.D0","article-title":"Lysophophatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor","volume":"23","author":"Chang","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2004.07.017","article-title":"Linoleic acid increases monocyte deformation and adhesion to endothelium","volume":"177","author":"Rinker","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib19","first-page":"299","article-title":"Increased lysophosphaidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL","volume":"177","author":"Benitez","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.CIR.0000082307.85449.1D","article-title":"Plaque rupture, lysophosphatidic acid, and thrombosis","volume":"108","author":"Spector","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2006.06.008_bib21","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.ATV.0000040598.18570.54","article-title":"Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques","volume":"22","author":"Rikitake","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/14728222.7.3.427","article-title":"Secreted phospholipase A2 enzymes as therapeutic targets","volume":"7","author":"Scott","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbalip.2006.06.008_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","article-title":"The expanding superfamily of phospholipase A2 enzymes: classification and characterization","volume":"1488","author":"Six","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib24","first-page":"328","article-title":"Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regiones in mouse and human","volume":"32","author":"Tischfield","year":"1996","journal-title":"Genetics"},{"key":"10.1016\/j.bbalip.2006.06.008_bib25","doi-asserted-by":"crossref","first-page":"7946","DOI":"10.1073\/pnas.141239098","article-title":"Localization of atherosclerosis susceptibility loci to chromosome 4 and 6 using the LDLr knockout mouse model","volume":"98","author":"Welch","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbalip.2006.06.008_bib26","doi-asserted-by":"crossref","first-page":"22378","DOI":"10.1074\/jbc.270.38.22378","article-title":"A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains","volume":"270","author":"Kennedy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.19.5.1284","article-title":"Role of group II secretoty phospholipase A2 in atherosclerosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2","volume":"19","author":"Ivandic","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.ATV.0000051701.90972.E5","article-title":"Macrophage-expressed group IIA sPLA2 increases atherosclerotic lesion formation in LDL receptor-deficient mice","volume":"23","author":"Webb","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib29","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1194\/jlr.M400469-JLR200","article-title":"Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress","volume":"46","author":"Tietge","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib30","doi-asserted-by":"crossref","first-page":"31435","DOI":"10.1074\/jbc.274.44.31435","article-title":"Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A2s in regulating arachidonic acid release and prostaglandin generation","volume":"274","author":"Murakami","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib31","doi-asserted-by":"crossref","first-page":"48535","DOI":"10.1074\/jbc.M205855200","article-title":"Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X and XII secreted phospholipase A2","volume":"277","author":"Singer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib32","doi-asserted-by":"crossref","unstructured":"I. Kudo, M. Murakami, Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 2002;68\u201369:3\u201358.","DOI":"10.1016\/S0090-6980(02)00020-5"},{"key":"10.1016\/j.bbalip.2006.06.008_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2005.10.005","article-title":"Secretory phopsholipase A2 of group IIA: is an offensive or defensive player during atherosclerosis and other inflammatory diseases?","volume":"79","author":"Menschikowski","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbalip.2006.06.008_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the centers for disease control and prevention and the american heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2006.06.008_bib35","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset","volume":"26","author":"W\u00e5llberg-Jonsson","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"4","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2006.06.008_bib37","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Rheumatoid arthritis patients have elevated levels of small low density lipoprotein with high affinity for arterial matrix components: possible contribution of phoshoplipase A2 to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2006.06.008_bib38","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0022-2275(20)34937-3","article-title":"Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism","volume":"38","author":"de Beer","year":"1997","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bbalip.2006.06.008_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1007061413234","article-title":"Expression of human secretory group IIA phospholipase A2 is associated with reduced concentrations of plasma cholesterol in transgenic mice","volume":"24","author":"Menschikowski","year":"2000","journal-title":"Inflammation"},{"key":"10.1016\/j.bbalip.2006.06.008_bib40","first-page":"E403","article-title":"Acute inflamation increases selective uptake of HDL cholesteryl esters into adrenals of mice overexpressing human sPLA2","volume":"285","author":"Tietge","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib41","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2006.06.008_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0008-6363(00)00060-2","article-title":"Increase in plasma levels of secretory type II phospholipase A2 in patients with coronary spastic angina","volume":"47","author":"Kugiyama","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s003950070041","article-title":"Level of circulating phospholipase A2 in prediction of the prognosis of patients with suspected myocardial infarction","volume":"5","author":"Porela","year":"2000","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2005.06.056","article-title":"Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes","volume":"46","author":"Mallat","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000157933.19424.b7","article-title":"Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women. The EPIC-Norfolk prospective population study","volume":"25","author":"Boekholdt","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib46","first-page":"55","article-title":"CRP, interlukin 6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up","volume":"108","author":"Hartford","year":"2006","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.bbalip.2006.06.008_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.ATV.21.2.269","article-title":"Antibodies against oxidized LDL in relation to cell-adhesion molecules, snpPLA2 and carotid atherosclerosis in patients with hypercholesterolemia","volume":"21","author":"Hulthe","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2796.2001.00827.x","article-title":"Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolemia","volume":"249","author":"Wiklund","year":"2001","journal-title":"J. Int. Med."},{"key":"10.1016\/j.bbalip.2006.06.008_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(02)00371-4","article-title":"Insulin resistance and adipocity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes","volume":"166","author":"Leinonen","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/ddi453","article-title":"Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2-IIa: results from the UDACS study","volume":"15","author":"Wotton","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2006.06.008_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0925-4439(00)00050-8","article-title":"Sera of patients suffering from inflamatory diseases contain group IIA but not group V phospholipase A2","volume":"1502","author":"Aarsman","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0021-9150(95)05604-1","article-title":"Secretory group II phospholipase A2 in human atherosclerotic plaques","volume":"118","author":"Menschikowski","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.ATV.17.2.300","article-title":"Localization of non pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low density lipoprotein","volume":"17","author":"Hurt-Camejo","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib54","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.ATV.17.10.2257","article-title":"Expression of phosholipase A2 isoforms in human normal and atherosclerotic arterial wall","volume":"17","author":"Elinder","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.ATV.18.4.519","article-title":"Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries","volume":"18","author":"Romano","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib56","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.RES.86.6.707","article-title":"Molecular basis for the association of group IIA phospholipase A2 and decorin in human atherosclerotic lesions","volume":"86","author":"Sartipy","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9150(04)90634-X","article-title":"Secretory phospholipase A2 type IIA and V in atherosclerosis: expression by vascular cells, localization in lesions and hydrolysis of lipoproteins","volume":"5","author":"Rosengren","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.ATV.0000122363.02961.c1","article-title":"Group V sPLA2 hydrolysis of low-desnity lipoprotein results in spontaneous particle aggregation and promotes macrophages foam cell formation","volume":"24","author":"Wooton-Kee","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.ATV.0000221231.56617.67","article-title":"Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans and induction in aorta by a western diet","volume":"26","author":"Rosengren","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib60","doi-asserted-by":"crossref","first-page":"22895","DOI":"10.1074\/jbc.M002783200","article-title":"IFN-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation and modulation byother cytokines","volume":"275","author":"Peilot","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib61","doi-asserted-by":"crossref","first-page":"32381","DOI":"10.1074\/jbc.271.50.32381","article-title":"Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages","volume":"271","author":"Balboa","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib62","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.ATV.20.5.1276","article-title":"Mildly oxidized LDL induces expression of group IIa secretory phospholipase A2 in human monocyte-derived macrophages","volume":"20","author":"Anthonsen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib63","doi-asserted-by":"crossref","first-page":"16488","DOI":"10.1074\/jbc.M313748200","article-title":"Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability reveald by target gene distruption","volume":"279","author":"Satake","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib64","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1074\/jbc.M508314200","article-title":"Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis","volume":"281","author":"Balestrieri","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib65","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1074\/jbc.275.14.10077","article-title":"Overexpression of secretory phospholipase A2 causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I","volume":"275","author":"Tietge","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib66","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/bi015757x","article-title":"Role of group IIa and group V secretory phospholipase A2 in the metabolism of lipoproteins. Substrate specificities of the enzymesand the regulation of their activities by sphingomyelin","volume":"41","author":"Gesquiere","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2006.06.008_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1388-1981(00)00109-8","article-title":"Structure, function, and regulation of group V phospholipase A2","volume":"1488","author":"Cho","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib68","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M004604200","article-title":"Mechanism of human group V phospholipase A2 (PLA2) induced leukotriens biosynthesis in human neutrophils. A potential role of heparn sulfate binding in PLA2 internalization and degradation","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib69","doi-asserted-by":"crossref","first-page":"32746","DOI":"10.1074\/jbc.M502067200","article-title":"Group V secretory phsopholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independnet process that involeves cellular proteoglycans","volume":"280","author":"Boyanovsky","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2006.06.008_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-4889(03)00120-4","article-title":"Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions","volume":"1642","author":"Ishimoto","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib71","first-page":"533","article-title":"Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristsics, and the proximity of platelet-derived growth factor and transforming growth factors-b","volume":"152","author":"Evanko","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib72","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.RES.0000126921.29919.51","article-title":"Proteoglycans in atherosclerosis and restenosis: key roles for versican","volume":"94","author":"Wight","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2006.06.008_bib73","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/01.ATV.18.12.1934","article-title":"Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes","volume":"18","author":"Sartipy","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib74","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1021\/bi971200z","article-title":"Mapping the interfacial binding surface of human secretory group IIa phospholipase A2","volume":"36","author":"Snitko","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2006.06.008_bib75","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/bi051901t","article-title":"Computational analysis of the membarne association of group IIA secreted phospholipase A2: a differential role for electrostatics","volume":"45","author":"Diraviyam","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2006.06.008_bib76","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.4049\/jimmunol.162.12.7402","article-title":"Protection bt group II phospholipase A2 against Staphylococcus aureus","volume":"162","author":"Laine","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbalip.2003.10.004","article-title":"Induction of distinct sets of secretory phospholipase A2 in rodents during inflammation","volume":"1635","author":"Hamaguchi","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2006.06.008_bib78","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2006.06.008_bib79","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.CIR.0000136819.93989.E1","article-title":"Increased in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice","volume":"110","author":"Lewis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2006.06.008_bib80","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.ATV.19.5.1291","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis. 2. Potential involvement of biologically active oxidized phospholipids","volume":"19","author":"Leitinger","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2006.06.008_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9150(99)00045-3","article-title":"Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis","volume":"144","author":"Schiering","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2006.06.008_bib82","first-page":"4007","article-title":"Reduntant and segragated functions of granule-associated heparin-binding group II subfamily of secretory phospholipase A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells","volume":"165","author":"Enomoto","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198106001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198106001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:43:28Z","timestamp":1683506608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198106001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1388198106001910"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2006.06.008","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}